Eli Lilly Announces $140 Million Expansion In Indianapolis

The Indianapolis-based drug manufacturer plans to expand its insulin manufacturing facility.

Eli Lilly employees in lab

Photo: Eli Lilly

Eli Lilly employees run tests in a laboratory.

Eli Lilly has announced a $140-million expansion of its Indianapolis insulin manufacturing facility.

The new facility will manufacture insulin cartridges to meet the growing diabetes demand in the U.S. Company officials say it is one of the most significant investments in its U.S.-based manufacturing operations in the past 10 years and will be a first-of-its-kind facility for Lilly in the U.S.

Eli Lilly president of global manufacturing Maria Crowe says Lilly decided to add insulin-cartridge manufacturing to its Indianapolis plant, rather than expand existing operations in Europe. The facility will employ 100 full-time workers once it is fully operational. Construction should be complete in March 2014.

Network Indiana

Network Indiana Indiana's Only Audio News Network. Network Indiana is dedicated to providing the state of Indiana important and useful information.

View all posts by this author »

What is RSS? RSS makes it possible to subscribe to a website's updates instead of visiting it by delivering new posts to your RSS reader automatically. Choose to receive some or all of the updates from Indiana Public Media News:

Support For Indiana Public Media Comes From

Search News

Stay Connected

RSS e-mail itunes Facebook Twitter Flickr YouTube

Follow us on Twitter

What is RSS? RSS makes it possible to subscribe to a website's updates instead of visiting it by delivering new posts to your RSS reader automatically. Choose to receive some or all of the updates from Indiana Public Media News:

Recent Business & Economy Stories

Recent Videos

Find Us on Facebook